A bi-specific inhibitor targeting IL-17A and MMP-9 reduces invasion and motility in MDA-MB-231 cells

The cytokine IL-17A is associated with the progression of various cancers, but little is known about the molecular cross-talk between IL-17A and other tumor-promoting factors. Previous studies have shown that the IL-17A-mediated invasion of breast cancer cells can be inhibited by selective antagonis...

Descripción completa

Detalles Bibliográficos
Autores principales: Koslawsky, Dana, Zaretsky, Marianna, Alcalay, Ron, Mazor, Ohad, Aharoni, Amir, Papo, Niv
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033355/
https://www.ncbi.nlm.nih.gov/pubmed/29983876
http://dx.doi.org/10.18632/oncotarget.25526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6033355/
https://www.ncbi.nlm.nih.gov/pubmed/29983876
http://dx.doi.org/10.18632/oncotarget.25526

Ejemplares similares